The Wales Market
Wales's Pharmaceuticals & Life Sciences market — centered in Cardiff, with significant NHS Wales presence — operates under UK frameworks with devolved policy dimensions. NHS Wales operates independently of NHS England with its own digital strategy and procurement processes. The Welsh Government's technology priorities and Senedd oversight create distinct policy context for public sector technology deployment.
Engineering teams serving Welsh Pharmaceuticals & Life Sciences organizations need UK regulatory fluency with Welsh devolution context — NHS Wales's distinct governance, the Welsh Government's digital strategy, and the Welsh language requirements for public-facing digital services. We deploy with all dimensions mapped.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Wales is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Wales. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Wales. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Wales. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.